33med

title: "Protecting IP from LLM Training Data"
description: "Discover how 33MED's air-gapped, local-execution architecture guarantees your proprietary ligand structures and computational immunology data remain completely isolated from public LLM training pipelines."
date: 2024-05-24
author: "33MED Engineering"
category: "Enterprise B2B Architecture & Security"

Protecting IP from LLM Training Data: How 33MED Ensures Your Ligand Structures Never Become Open-Source Knowledge

In the race to accelerate drug discovery and computational immunology, biopharma enterprises are increasingly relying on artificial intelligence. But this acceleration comes with a hidden, potentially catastrophic cost: Intellectual Property leakage.

When structural biologists pass novel ligand designs, SMILES strings, or proprietary protein targets into cloud-hosted LLMs or non-commercial AI wrappers, that data often enters a training pipeline. Your multi-million-dollar molecular targets risk becoming part of the open-source weights of tomorrow's foundational models.

At 33MED, we are building autonomous biotech infrastructure that treats data sovereignty as a baseline, not a premium feature. Our ImmuNav platform—a foundational engine for computational immunology and surgical robotics—is engineered from the ground up to guarantee that your proprietary molecular structures never touch a third-party server.

Here is how 33MED structurally isolates your IP using a highly performant, mathematically rigorous, and commercially safe architecture.


The GenAI Boundary: Restricting LLMs to Public Knowledge

The cardinal rule of the 33MED architecture is strict functional isolation. Large Language Models are phenomenally powerful at semantic extraction, but they have no business handling proprietary structural payloads.

We utilize foundational models (like Gemini) exclusively at the public data ingestion layer.

Our automated Node.js background agents harvest raw, open-source XML data directly from PubMed (via NCBI Entrez E-utilities) and the arXiv API. When this raw public data lands in our backend, we pass the text chunks to the LLM to extract explicit molecular targets, binding affinities, and genetic expressions into structured, Zod-validated JSON arrays.

Because the LLM is only fed public scientific literature, your proprietary data is never exposed. The model acts merely as a highly efficient research assistant, curating public knowledge to fuel our local, private synthesis engine.


The Core Matrix: Native, Local Execution of Physical Models

To safely build a commercial SaaS platform without licensing pitfalls or cloud-leakage risks, 33MED explicitly bypasses restricted cloud tools (such as AlphaFold 3’s non-commercial web wrappers). Instead, we orchestrate fully open, commercial-safe alternatives natively.

By keeping execution entirely focused on a lean Node.js, MongoDB, and React ecosystem, we utilize native child_process CLI execution to spawn physical computations locally. Your data remains strictly on your enterprise hardware.

Our secure tool matrix includes:


The MongoDB Swarm Engine: Zero-Leak Orchestration

Complex message brokers and distributed cloud queues introduce unnecessary vulnerabilities. 33MED’s ImmuNav engine achieves asynchronous task orchestration by utilizing MongoDB as a highly durable, atomic task queue.

Our Simulation Worker relies on a lightweight, recursive polling loop that queries MongoDB for actionable jobs. By relying on native database querying to track agent parameters and pipeline status, we eliminate the need for external state management.

When a task—such as an energy minimization run—is queued, our Node.js runtime natively spawns the required binary (e.g., GROMACS). Standard error and output streams (stderr/stdout) are piped directly back into the MongoDB task document as runtime logs.

To ensure absolute stability and safety during development and scaling, we validate this pipeline locally using micro-dataset testing protocols. By running local energy minimizations on standard benchmarking structures—like Hen Egg White Lysozyme (PDB: 1AKI)—we verify that our local Node runtime processes exit codes and stdout string parsing flawlessly, completely independent of external API quotas or cloud compute.


Human-In-The-Loop (HITL): Absolute Executive Control

Autonomous biotech infrastructure is only viable if it remains under strict human oversight. To guarantee executive control over our AI agents without modifying code or touching environment configurations, 33MED deploys a native React Control Center.

This dashboard acts as an unbreachable gateway between agent-generated hypotheses and hardware execution.

  1. The Global Interrupter: A hard toggle in the UI immediately updates a global isPaused state in MongoDB. Our backend workers check this boolean before processing any queued document, allowing you to halt the entire swarm instantly without corrupting active calculations.
  2. Mandatory Approval Gates: When our bioinformatics agents design a simulation run (e.g., small-molecule inhibitor binding parameters), the task enters a pending_review state.
  3. Local Parameter Verification: Scientists can view, verify, and manually tweak the Zod-validated parameters directly in the dashboard. Until a human clicks Approve, the payload cannot hit the local hardware execution loop.

Securing the Future of Biotech

The future of computational immunology and surgical robotics belongs to organizations that can leverage AI at scale without compromising their foundational assets. By stripping away academic bloat, bypassing leaky cloud wrappers, and orchestrating commercial-safe physical models on local hardware, 33MED ensures your intellectual property remains exactly that: yours.

33MED: Autonomous infrastructure. Absolute data sovereignty.```